Teste Repositóri
2014-01-01
Resultados de pesquisa
Foram encontrados 5 registos.
O Sarcoma de Kaposi (SK) é uma neoplasia multifocal, de expressão predominantemente cutânea, mas que pode atingir órgãos viscerais. Estão descritas quatro variantes: o SK clássico, o endémico africano, o iatrogénico e o epidémico. Esta última variante surgiu com a associação deste tumor à SIDA e tomou proporções importantes, tanto pela sua frequência como pela expressão clínica disseminada com atingimento visceral marcado. Os homossexuais constituem o grupo de risco mais afectado e admitem-se várias hipóteses etiológicas para esta neoplasia. Existe uma correlação entre o grau de deficiência imunológica e a extensão da doença. O SK associado à SIDA apresenta envolvimento visceral em 50 a 70% dos casos. No entanto, o envolvimento visceral isolado é raro. Descrevem-se as expressões gastro-intestinal, pulmonar e cardíaca da doença, por ser...
Primary hyperparathyroidism _HPT. is associated with generalized skeletal changes, its full-blown osseous manifestations known as osteitis fibrosa cystica. Fibrous dysplasia _FD., a benign bone disorder, is differentiated from generalized fibrocystic disease caused by hyperparathyroidism. The classic triad of McCune–Albright syndrome includes polyostotic FD, patchy skin pigmentation, and sexual precocity. Other associated endocrinopathies are hyperthyroidism, Cushing’s syndrome, acromegaly, and HPT. We describe a patient with severe generalized and focal bone lesions and sexual precocity. HPT was diagnosed and treated with persistence of cystic bone lesions.
The similarities between HPT and FD are discussed, focusing on a possible genetically determined mechanism to explain the relationship between them.
Cerebrospinal fluid (CSF) 14-3-3 protein supports sporadic Creutzfeldt-Jakob (sCJD) diagnosis, but often leads to weak-positive results and lacks standardization. In this study, we explored the added diagnostic value of Total Tau (t-Tau) and phosphorylated Tau (p-Tau) in sCJD diagnosis, particularly in the cases with inconclusive 14-3-3 result. 95 definite sCJD and 287 patients without prion disease (non-CJD) were included in this study. CSF samples were collected in routine clinical diagnosis and analysed for 14-3-3 detection by Western blot (WB). CSF t-Tau and p-Tau were quantified by commercial ELISA kits and PRNP and APOE genotyping assessed by PCR-RFLP. In a regression analysis of the whole cohort, 14-3-3 protein revealed an overall accuracy of 82 % (sensitivity = 96.7 %; specificity = 75.6 %) for sCJD. Regarding 14-3-3 clear posi...
